If itching persists beyond 2-3 weeks or worsens despite conservative management, switching to oral semaglutide or exploring alternative compounds like tirzepatide may reduce skin-related symptoms
Maintaining adequate hydration is particularly important with this combination
The dataset connects claims, labs and EHR, including physician notes to analyse: Who meets drug label or payer criteria based on actual BMI and comorbidities How titration and dosing progress in real-world care What metabolic outcomes patients achieve over time Which safety signals, such as liver or renal changes, emerge across populations Why patients discontinue or switch treatments, as documented in notes See real-world GLP-1 evidence in action Register for our webinar where we dive deeper into GLP-1 real-world evidence
Ultimately, GLP-1 was identified as a potential incretin hormone (89, 91)
Our certification means our weight loss program meets independently verified standards for legality, safety, and transparency
As with any metabolic medication, there are important precautions to follow